文献速递糖尿病

糖尿病预防计划/糖尿病预防计划结局研究中痛性神经病变症状与远端对称性多神经病变(DSPN)的非血糖及血糖危险因素

Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.
PubMed 文献 · Diabetes Care · 2025-01-01

在糖尿病预防计划/糖尿病预防计划结局研究(DPP/DPPOS)随机分组约21年后,评估1779名参与者的神经病变,按密歇根神经病变筛查量表(MNSI)问卷症状与针刺、振动、单丝检查体征分为四种互斥表型。501人(28%)无症状无体征,144人(8%)有痛性神经病变症状但无体征,473人(27%)为DSPN;痛性症状与女性、体重较大、估算肾小球滤过率较低相关,与血糖无关,而DSPN与年龄较大、白人种族及血糖暴露相关。

要点

  • 痛性神经病变症状与女性、体重较大、估算肾小球滤过率较低相关,与血糖无关。
  • DSPN与年龄较大、白人种族及血糖暴露相关。
  • 痛性神经病变症状与DSPN的危险因素不同,改进识别与诊断标准共识可能促进相关研究。

核心结论

  • 在该队列中,痛性神经病变症状与DSPN的危险因素不同。
  • 改进对痛性神经病变症状的识别并提高诊断标准共识,可能促进对其病因、预防和治疗的研究。

研究设计与样本

  • 对1779名DPP/DPPOS参与者在DPP随机分组约21年后评估神经病变。
  • 用MNSI问卷评估症状,用针刺、振动和单丝检查评估体征。
  • 定义四种互斥神经病变表型:无症状无体征、无体征的痛性神经病变症状、无痛无体征的其他神经系统症状、DSPN(MNSI问卷评分≥4或任何体征)。
  • 采用多项logistic回归模型比较非血糖和血糖危险因素。

主要发现

  • 501人(28%)无症状无体征,144人(8%)有痛性神经病变症状但无体征,473人(27%)为DSPN。
  • 与无症状无体征者相比,有痛性神经病变症状者更可能为女性、体重较大、估算肾小球滤过率较低。
  • 痛性症状与血糖无关。
  • 与痛性症状相比,DSPN与年龄较大、白人种族及血糖暴露相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The clinical presentation, symptoms, and signs of neuropathy vary substantially. We determined whether painful neuropathic symptoms and distal symmetrical polyneuropathy (DSPN) were associated with different risk factors in a longitudinal study of Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study (DPP/DPPOS) participants. RESEARCH DESIGN AND METHODS: We assessed neuropathy in 1,779 DPP/DPPOS participants ∼21 years after DPP randomization. Symptoms were assessed using the Michigan Neuropathy Screening Instrument (MNSI) questionnaire and signs using pinprick, vibration, and monofilament testing. We defined four mutually exclusive neuropathy phenotypes: 1) no symptoms or signs of DSPN, 2) neuropathic pain without signs, 3) other neurologic symptoms without pain or signs, and 4) DSPN (MNSI questionnaire score ≥4 or any signs). We used multinomial logistic regression models to compare nonglycemic and glycemic risk factors among participants to better understand risk factors associated with painful neuropathic symptoms and DSPN. RESULTS: Among the participants, 501 (28%) had no symptoms or signs, 144 (8%) had painful neuropathic symptoms without signs, and 473 (27%) had DSPN. Compared with participants with neither symptoms nor signs, those with painful neuropathic symptoms were more likely to be women, to have greater weight, and lower estimated glomerular filtration rate. Painful symptoms were not associated with glycemia. In contrast, DSPN, when compared with painful symptoms, was associated with older age, White race, and glycemic exposure. CONCLUSIONS: In this cohort, risk factors for painful neuropathic symptoms and DSPN differed. Improved recognition of painful neuropathic symptoms and better consensus on diagnostic criteria may facilitate research into their causes, prevention, and treatment.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Herman WH, Ciarleglio A, Callaghan BC, et al. Nonglycemic and Glycemic Risk Factors for Painful Neuropathic Symptoms and for Distal Symmetrical Polyneuropathy (DSPN) in the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025. PMID: 40532190. doi:10.2337/dc25-0596

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。